HighTower Advisors’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.4K | Sell |
14,121
-7,365
| -34% | -$25.3K | ﹤0.01% | 3505 |
|
|
2025
Q1 | $47.9K | Sell |
21,486
-49,600
| -70% | -$111K | ﹤0.01% | 3412 |
|
|
2024
Q4 | $208K | Buy |
71,086
+60,600
| +578% | +$178K | ﹤0.01% | 3139 |
|
|
2024
Q3 | $27K | Sell |
10,486
-3,500
| -25% | -$9.01K | ﹤0.01% | 3411 |
|
|
2024
Q2 | $42K | Sell |
13,986
-30,088
| -68% | -$90.4K | ﹤0.01% | 3275 |
|
|
2024
Q1 | $200K | Buy |
44,074
+3,103
| +8% | +$14.1K | ﹤0.01% | 2966 |
|
|
2023
Q4 | $235K | Buy |
40,971
+6,928
| +20% | +$39.7K | ﹤0.01% | 2881 |
|
|
2023
Q3 | $158K | Buy |
+34,043
| New | +$158K | ﹤0.01% | 2977 |
|